Preferred Label : Lurasidone Hydrochloride;

MeSH definition : A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.;

MeSH synonym : Hydrochloride, Lurasidone; Lurasidone HCl; HCl, Lurasidone; 13496, SM; SM13496; SM-13496; SM-13,496; SM 13,496; SM13,496; N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide;

MeSH Hyperonym : lurasidone;

MeSH hyponym : SM 13496; Latuda;

Is substance : O;

Registry Number MeSH : O0P4I5851I;

MeSH Related Number : 22IC88528T; 367514-87-2 (lurasidone); 367514-88-3 (lurasidone hydrochloride);

Details


Main resources

You can consult :

A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002713/human_med_001737.jsp&mid=WC0b01ac058001d124
2014
false
Great Britain (UK)
French
English
drug approval
europe
adult
schizophrenia
lurasidone
administration, oral
antipsychotic agents
antipsychotic agents
treatment outcome
product surveillance, postmarketing
drug monitoring
drug interactions
pregnancy
breast feeding
multicenter studies as topic
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed
Lurasidone Hydrochloride
Lurasidone Hydrochloride
Oral form lurasidone (product)

---
Summary Basis of Decision (SBD) for Latuda
Lurasidone Hydrochloride (HCl), 40 mg, 80 mg, and 120 mg, Tablets, Oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?linkID=SBD00084
2012
false
Canada
French
English
Lurasidone Hydrochloride
Lurasidone Hydrochloride
drug information
Oral form lurasidone (product)
drug approval
canada
administration, oral
antipsychotic agents
antipsychotic agents
schizophrenia
receptors, dopamine d2
receptor, serotonin, 5-ht2a
drug evaluation, preclinical
drug interactions
treatment outcome
clinical trials, phase ii as topic
clinical trials, phase iii as topic
risk assessment
lurasidone

---
E-mail
21/10/2017


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.